Amex Global Business Travel agrees to $5.3bn deal with Apollo SPAC, Carlyle invests in GTCR-backed Resonetics

The merger includes $335 million private investment in public equity (PIPE) financing from new investors; the Carlyle deal continues the firm's focus on medical products businesses.

Share this